Articolo in rivista, 2018, ENG, 10.1063/1.5047780
Colone, Marisa; Angiolella, Letizia; Vitali, Alberto; Serra, Stefano; Gori, Alessandro; Calcabrini, Annarica; Stringaro, Annarita
Università degli Studi di Roma La Sapienza; Università Cattolica del Sacro Cuore, Rome; Consiglio Nazionale delle Ricerche; Istituto Superiore Di Sanita
One of the main prerequisite of a therapeutic drug is to overcome a series of physiological barriers and it to be less toxic for the human. To this aim, it is necessary to find a carrying vector able to enhance drug internalization and to improve its therapeutic efficacy. Presently, biocompatible and biodegradable nanoparticles (NPs) as some effective drug delivery devices, are widely studied. In order to increase the antimicrobial and antitumor efficacy of different natural products numerous studies are in progress to evaluate different drug delivery systems (cationic liposomes, lysozyme-shelled hollow nanoimicrobubbles and nanoimicrocapsules). This delivery system would have a synergistic and additive effect decreasing the drug resistance reactions too. The present article has tried to review some of the latest research on nanocarriers in clinical care.
AIP conference proceedings 1990
Serra Stefano, Vitali Alberto, Gori Alessandro
ID: 404024
Year: 2018
Type: Articolo in rivista
Creation: 2019-07-03 09:32:39.000
Last update: 2021-04-05 11:14:01.000
CNR authors
CNR institutes
External links
OAI-PMH: Dublin Core
OAI-PMH: Mods
OAI-PMH: RDF
DOI: 10.1063/1.5047780
URL: http://www.scopus.com/record/display.url?eid=2-s2.0-85050720146&origin=inward
External IDs
CNR OAI-PMH: oai:it.cnr:prodotti:404024
DOI: 10.1063/1.5047780
ISI Web of Science (WoS): 000443961900026
Scopus: 2-s2.0-85050720146